In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
Five Trends That Got Everyone Talking in Pharma and Biotech This Year Read More »
C-suite executives surveyed said they think new technology leadership roles will become more important in the next three years, according to a report from the Healthcare Financial Management Association.
Health system leaders need to evolve in the face of AI: report Read More »
The lowest level of quarterly VC funding since 2023 has tempered expectations that the sector will achieve its best year since 2021.
The strategic initiative will extend Metagenomi’s cash runway into the fourth quarter of 2027. That same year, the company expects to generate initial Phase I data for its lead asset MGX-001 in hemophilia A.
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program Read More »
Aside from offering to acquire all remaining shares of Neuphoria, existing investor Lynx1 Master Fund also announced its plan to nominate directors in the biotech’s upcoming board elections.
Altimmune’s pemvidutide showed “class-leading signals” in non-invasive assessments and has “potentially best-in-class tolerability,” according to analysts at H.C. Wainwright.
Altimmune Poised For $1B+ Opportunity as MASH Drug Aces Phase IIb Read More »
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the third quarter, the pipeline-in-a-product strategy has never been more attractive.
Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space Read More »
El conjunto de satélites Sentinel-1, que proporciona visión por radar al programa de observación de la Tierra Copernicus, cuenta con una nueva incorporación a su familia gracias a la puesta en órbita del Sentinel-1D, el último de la innovadora primera genera …
El satélite Sentinel-1D a punto de comenzar sus operaciones Read More »
En el ámbito del origen de la vida, la hipótesis del “Mundo de ARN” sostiene que este tipo de ácido nucleico fue anterior al ADN y a las proteínas. Así, las formas de vida primitivas se habrían basado en moléculas de ARN capaces de almacen …
La inesperada contribución de la Luna al surgimiento de vida en la Tierra Read More »
Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives from Novo and Eli Lilly to the White House to announce that the companies’ GLP-1 medicines would be sold at a reduced cost; and the FDA grants the second round of priority review vouchers—primarily to already
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers Read More »
